| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |